erlotinib hydrochloride has been researched along with betadex in 2 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (betadex) | Trials (betadex) | Recent Studies (post-2010) (betadex) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 8,785 | 97 | 4,452 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devasari, N; Dora, CP; Kumar, V; Paidi, SR; Singh, C; Sobhia, ME; Suresh, S | 1 |
| Akkın, S; Bilensoy, E; Erdoğar, N; Varan, G | 1 |
2 other study(ies) available for erlotinib hydrochloride and betadex
| Article | Year |
|---|---|
Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Topics: Administration, Oral; Animals; beta-Cyclodextrins; Biological Availability; Carbohydrate Conformation; Chemistry, Pharmaceutical; Drug Carriers; Drug Liberation; Erlotinib Hydrochloride; Models, Molecular; Rats; Rats, Sprague-Dawley; Solubility | 2015 |
Erlotinib complexation with randomly methylated
Topics: A549 Cells; Animals; Antineoplastic Agents; beta-Cyclodextrins; Caco-2 Cells; Calorimetry, Differential Scanning; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Liberation; Erlotinib Hydrochloride; Humans; Intestinal Absorption; Lung Neoplasms; Methylation; Mice; Microscopy, Electron, Scanning; Solubility; Treatment Outcome | 2021 |